Similar articles

• The psychobiology of premenstrual dysphoria: the role of prolactin.

  Carroll BJ, Steiner M. Carroll BJ, et al. Psychoneuroendocrinology. 1978 Apr;3(2):171-80. doi: 10.1016/0306-4530(78)90005-7. Psychoneuroendocrinology. 1978. PMID: 568295 No abstract available.
• Dydrogesterone in the treatment of the premenstrual syndrome.

  Kerr GD, Day JB, Munday MR, Brush MG, Watson M, Taylor RW. Kerr GD, et al. Practitioner. 1980 Aug;224(1346):852-5. Practitioner. 1980. PMID: 7001428 Clinical Trial. No abstract available.
• No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder.

  Hsiao CC, Liu CY, Hsiao MC. Hsiao CC, et al. Psychiatry Clin Neurosci. 2004 Dec;58(6):593-9. doi: 10.1111/j.1440-1819.2004.01308.x. Psychiatry Clin Neurosci. 2004. PMID: 15601382 Clinical Trial.
• [Premenstrual syndrome and its treatment. The role of progestagens].

  Bursaux CD, Paris J, Pintiaux C, Delecour M, Belaisch J, Rozenbaum H. Bursaux CD, et al. Rev Fr Gynecol Obstet. 1985 Oct;80(10):753-62. Rev Fr Gynecol Obstet. 1985. PMID: 3909348 Review. French. No abstract available.
• Drug therapy for the premenstrual syndrome.

  Shangold MM. Shangold MM. J Reprod Med. 1983 Aug;28(8):525-6. J Reprod Med. 1983. PMID: 6355467 Review.